Actrapid

BIOLOGICAL4 trials

Sponsors

Mannkind Corporation, Wockhardt, Turku University Hospital

Conditions

DiabetesInsulin ResistanceType 2 Diabetes Mellitus

Phase 1

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.

CompletedNCT00719108

WockhardtDiabetes

Start: 2008-07-31End: 2008-09-30Updated: 2012-12-27

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics

CompletedNCT00752180

WockhardtDiabetes

Start: 2008-08-31End: 2009-04-30Updated: 2012-12-27

Phase 2

Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes

CompletedNCT00511719

Mannkind CorporationType 2 Diabetes Mellitus

Start: 2004-02-29End: 2005-03-31Updated: 2011-06-29

Unknown Phase

Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity

CompletedNCT02933645

Turku University HospitalInsulin Resistance

Start: 2016-04-30End: 2016-12-31Updated: 2018-01-26